跳至主要内容
临床试验/ISRCTN45162540
ISRCTN45162540已完成不适用

The role of Thalidomide in Reversing Cachexia in Patients with Oesophageal Cancer

Record Provided by the NHSTCT Register - 2006 Update - Department of Health0 个研究点目标入组 12 人开始时间: 2006年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 12 oesophageal cancer patients will be recruited from the endoscopy database.
  • 1. Patients with non obstructing and inoperable oesophageal cancer
  • 2. Able to swallow a semi solid diet (Dysphagia score <3)

排除标准

  • 1. Pre menopausal women
  • 2. Patients receiving any adjuvant chemo or radiotherapy
  • 3. Patients with oesophageal obstruction
  • 4. Patients with established neuropathy
  • 5. Patients requiring frequent laser ablation sessions
  • 6. Patients unable to take a constant calorific intake
  • 7. Increased debility

研究者

发起方
Record Provided by the NHSTCT Register - 2006 Update - Department of Health

相似试验